{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:13:17Z","timestamp":1785791597263,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31600748"],"award-info":[{"award-number":["31600748"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702006"],"award-info":[{"award-number":["81702006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870925"],"award-info":[{"award-number":["31870925"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Program for Infectious Disease of China","award":["2017ZX10202203"],"award-info":[{"award-number":["2017ZX10202203"]}]},{"name":"Science and Technology Innovation project","award":["2017J01066"],"award-info":[{"award-number":["2017J01066"]}]},{"name":"Fujian Provincial Medical Innovation Foundation","award":["2017-CXB-20"],"award-info":[{"award-number":["2017-CXB-20"]}]},{"DOI":"10.13039\/501100008865","name":"Xiamen University","doi-asserted-by":"publisher","award":["20720190124"],"award-info":[{"award-number":["20720190124"]}],"id":[{"id":"10.13039\/501100008865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.antiviral.2020.104757","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T04:05:49Z","timestamp":1583985949000},"page":"104757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Structure guided maturation of a novel humanized anti-HBV antibody and its preclinical development"],"prefix":"10.1016","volume":"180","author":[{"given":"Bing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maozhou","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruopeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104757_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.antiviral.2020.104757_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063359","article-title":"In silico driven redesign of a clinically relevant antibody for the treatment of GD2 positive tumors","volume":"8","author":"Ahmed","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.antiviral.2020.104757_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063359","article-title":"In silico driven redesign of a clinically relevant antibody for the treatment of GD2 positive tumors","volume":"8","author":"Ahmed","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104757_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fimmu.2014.00372","article-title":"Structure based refinement of a humanized monoclonal antibody that targets tumor antigen disialoganglioside GD2","volume":"5","author":"Ahmed","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2020.104757_bib5","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1021\/bc100261d","article-title":"Effects of charge on antibody tissue distribution and pharmacokinetics","volume":"21","author":"Boswell","year":"2010","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.antiviral.2020.104757_bib6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1107\/S0907444998003254","article-title":"Crystallography & NMR system: a new software suite for macromolecular structure determination","volume":"54","author":"Brunger","year":"1998","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.antiviral.2020.104757_bib7","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1073\/pnas.0600997103","article-title":"Role of target geometry in phagocytosis","volume":"103","author":"Champion","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.antiviral.2020.104757_bib8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/19420862.2015.1076600","article-title":"Antibody humanization by structure-based computational protein design","volume":"7","author":"Choi","year":"2015","journal-title":"mAbs"},{"key":"10.1016\/j.antiviral.2020.104757_bib9","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.antiviral.2020.104757_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-pathol-011811-132445","article-title":"The cell biology of phagocytosis","volume":"7","author":"Flannagan","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.antiviral.2020.104757_bib11","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1080\/21645515.2017.1319021","article-title":"Antibody-mediated immunotherapy against chronic hepatitis B virus infection","volume":"13","author":"Gao","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2020.104757_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/protein\/gzq009","article-title":"Reduced elimination of IgG antibodies by engineering the variable region","volume":"23","author":"Igawa","year":"2010","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.antiviral.2020.104757_bib13","series-title":"A novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys","author":"Kang","year":"2017"},{"key":"10.1016\/j.antiviral.2020.104757_bib14","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1080\/21645515.2018.1449553","article-title":"The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice","volume":"14","author":"Kang","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2020.104757_bib15","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","article-title":"Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication","volume":"41","author":"Ladner","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104757_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK-a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.antiviral.2020.104757_bib17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4161\/mabs.29809","article-title":"Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge","volume":"6","author":"Li","year":"2014","journal-title":"mAbs"},{"key":"10.1016\/j.antiviral.2020.104757_bib18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104757_bib19","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nbt1363","article-title":"The growth and potential of human antiviral monoclonal antibody therapeutics","volume":"25","author":"Marasco","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2020.104757_bib20","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nbt1363","article-title":"The growth and potential of human antiviral monoclonal antibody therapeutics","volume":"25","author":"Marasco","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2020.104757_bib21","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/jcc.540130714","article-title":"Validation of the general purpose QUANTA 3.2\/CHARMm force field","volume":"13","author":"Momany","year":"1992","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.antiviral.2020.104757_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.antiviral.2020.104757_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060989","article-title":"Effects of microparticle size and Fc density on macrophage phagocytosis","volume":"8","author":"Pacheco","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104757_bib24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1107\/S0907444903028956","article-title":"Likelihood-enhanced fast rotation functions","volume":"60","author":"Storoni","year":"2004","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.antiviral.2020.104757_bib25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/gutjnl-2015-310978","article-title":"A unique monoclonal antibody for therapeutic use against chronic hepatitis B: not all antibodies are created equal","volume":"65","author":"Sureau","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2020.104757_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/19420862.2015.1128606","article-title":"Molecular basis of high viscosity in concentrated antibody solutions: strategies for high concentration drug product development","volume":"8","author":"Tomar","year":"2016","journal-title":"mAbs"},{"key":"10.1016\/j.antiviral.2020.104757_bib27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/19420862.2017.1285479","article-title":"In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions","volume":"9","author":"Tomar","year":"2017","journal-title":"mAbs"},{"key":"10.1016\/j.antiviral.2020.104757_bib28","article-title":"A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5","volume":"6","author":"Xia","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104757_bib29","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/gutjnl-2014-308964","article-title":"Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen","volume":"65","author":"Zhang","year":"2016","journal-title":"Gut"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:31:47Z","timestamp":1759062707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219304723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":29,"alternative-id":["S0166354219304723"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104757","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure guided maturation of a novel humanized anti-HBV antibody and its preclinical development","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104757"}}